CAVERJECT IMPULSE alprostadil 10microgram powder for injection with 0.5mL diluent dual chamber cartridge in single use syringe device Australia - English - Department of Health (Therapeutic Goods Administration)

caverject impulse alprostadil 10microgram powder for injection with 0.5ml diluent dual chamber cartridge in single use syringe device

pfizer australia pty ltd - alprostadil, quantity: 20 microgram/ml - injection, solution - excipient ingredients: benzyl alcohol; water for injections - intracavernosal alprostadil (pge1) is indicated for the treatment of erectile dysfunction in adult males. intracavernosal alprostadil may be a useful adjunct to other diagnostic tests in the diagnosis of erectile dysfunction.

Caverject 20 micrograms Powder and Solvent for Solution for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

caverject 20 micrograms powder and solvent for solution for injection

pfizer healthcare ireland - alprostadil - powder and solvent for solution for injection - 20 microgram(s) - drugs used in erectile dysfunction; alprostadil

Prostin VR 500 microgram/1mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

prostin vr 500 microgram/1ml injection ampoule

pfizer australia pty ltd - alprostadil, quantity: 500 microgram/ml - injection, solution - excipient ingredients: ethanol - indications as at 14 january 1994: prostin vr sterile solution (alprostadil) is indicated for palliative, not definitive, therapy to temporarily maintain the patency of the ductus arteriosus until corrective or palliative surgery can be performed in neonates who have congenital heart defects and who depend upon a patent ductus for survival. such congenital heart defects include pulmonary atresia, pulmonary stenosis, tricuspid atresia, tetralogy of fallot, interruption of the aortic arch, coarctation of the aorta, mitral atresia, or transposition of the great vessels with or without other defects. prostin vr should be administered only by medically trained personnel in facilities in which paediatric patients can receive or have access to paediatric intensive care.

CAVERJECT IMPULSE alprostadil 20microgram powder for injection with 0.5mL diluent dual chamber cartridge in single use syringe device Australia - English - Department of Health (Therapeutic Goods Administration)

caverject impulse alprostadil 20microgram powder for injection with 0.5ml diluent dual chamber cartridge in single use syringe device

pfizer australia pty ltd - alprostadil, quantity: 40 microgram/ml - injection, solution - excipient ingredients: benzyl alcohol; water for injections - intracavernosal alprostadil (pge1) is indicated for the treatment of erectile dysfunction in adult males. intracavernosal alprostadil may be a useful adjunct to other diagnostic tests in the diagnosis of erectile dysfunction.

VIRIDAL DUO 20 Microgram/ML Pdr+Solv for Soln for Inj Ireland - English - HPRA (Health Products Regulatory Authority)

viridal duo 20 microgram/ml pdr+solv for soln for inj

ucb (pharma) ireland limited - alprostadil - pdr+solv for soln for inj - 20 microgram/ml - drugs used in erectile dysfunction

CAVERJECT IMPULSE- alprostadil injection, powder, lyophilized, for solution United States - English - NLM (National Library of Medicine)

caverject impulse- alprostadil injection, powder, lyophilized, for solution

u.s. pharmaceuticals - alprostadil (unii: f5td010360) (alprostadil - unii:f5td010360) - alprostadil 10 ug in 0.5 ml - caverject impulse is indicated for the treatment of erectile dysfunction. caverject impulse is indicated as an adjunct to other diagnostic tests in the diagnosis of erectile dysfunction. caverject impulse should not be used: - in men who have a known hypersensitivity to the drug [see adverse reactions (6.1)] - in men who have conditions that predispose them to priapism, such as sickle cell anemia or sickle cell trait, multiple myeloma, or leukemia [see warnings and precautions (5.1)] - for the treatment of erectile dysfunction in men with fibrotic conditions of the penis, such as anatomical deformation, angulation, cavernosal fibrosis, or peyronie's disease [see warnings and precautions (5.2)] - in men with penile implants. caverject impulse is not indicated for use in females. caverject impulse is not indicated for use in females. caverject impulse is not indicated for use in pediatric patients [see warnings and precautions (5.8)] . a total of 341 subjects included in clinical studies were 65 and older. no o

Alprostadil Injection USP
   
 
 Rx only United States - English - NLM (National Library of Medicine)

alprostadil injection usp rx only

teva parenteral medicines, inc. - alprostadil (unii: f5td010360) (alprostadil - unii:f5td010360) - alprostadil 500 ug in 1 ml - alprostadil injection usp is indicated for palliative, not definitive, therapy to temporarily maintain the patency of the ductus arteriosus until corrective or palliative surgery can be performed in neonates who have congenital heart defects and who depend upon the patent ductus for survival. such congenital heart defects include pulmonary atresia, pulmonary stenosis, tricuspid atresia, tetralogy of fallot, interruption of the aortic arch, coarctation of the aorta, or transposition of the great vessels with or without other defects. in infants with restricted pulmonary blood flow, the increase in blood oxygenation is inversely proportional to pretreatment po2 values; that is, patients with low po2 values respond best, and patients with po2 values of 40 torr or more usually have little response. alprostadil injection usp should be administered only by trained personnel in facilities that provide pediatric intensive care. none.

Caverject 10 micrograms Powder and Solvent for Solution for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

caverject 10 micrograms powder and solvent for solution for injection

pfizer healthcare ireland - alprostadil - powder and solvent for solution for injection - 10 microgram(s) - drugs used in erectile dysfunction; alprostadil